EUVIMEDEUVIMED entdecken
Crossref

Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia

Deivide DE Sousa Oliveira, Flávia Melo Cunha DE Pinho Pessoa, Isadora Lima Pontes, Kaira Mara DE Albuquerque Cordeiro, Beatriz Maria Dias Nogueira, Guilherme Passos DE Morais, Rodrigo Monteiro Ribeiro, Fabiana Aguiar Carneiro Silva, Lívia Andrade Gurgel, Manoel Odorico DE Moraes Filho, Maria Elisabete Amaral DE Moraes, Caroline Aquino Moreira-Nunes

Anticancer Research · 2025

DOI: 10.21873/anticanres.17690 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Deivide DE Sousa Oliveira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Drug Resistance, Multiple, Bacterial.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Acute myeloid leukemia (AML) is an aggressive hematological malignancy requiring intensive chemotherapy, which induces profound immunosuppression. Multidrug-resistant Gram-negative (MDRGN) bacterial colonization and infection are an emerging challenge in AML management, potentially worsening survival outcomes. This retrospective single-center cohort study evaluated the impact of MDRGN colonization and infection on overall survival (OS) in patients with AML undergoing chemotherapy. MATERIALS AND METHODS: MDRGN status was determined via routine cultures, while infection was defined by positive sterile-site cultures accompanied by clinical symptoms. Cytogenetic risk was stratified according to ELN 2022 criteria. Survival analysis was performed using the Kaplan-Meier method. RESULTS: A total of 64 patients with AML were analyzed, with a median OS of 8.03 months. MDRGN-colonized patients had significantly shorter OS (3.53 months) than non-colonized patients (18.83 months; p=0.024). High-risk cytogenetics independently reduced OS (4.63 vs. 18.93 months; p=0.011). Patients with both high-risk cytogenetics and MDRGN colonization had the poorest prognosis, with a median OS of 1.47 months. MDRGN colonization was associated with significantly increased infection risk, treatment-related complications, and reduced survival in AML. The combined effect of antimicrobial resistance and high-risk cytogenetics suggests a synergistic impact on prognosis. Delayed targeted antibiotic therapy, chemotherapy modifications, and increased septic episodes likely contributed to the observed mortality. CONCLUSION: MDRGN colonization is a critical negative prognostic factor in AML, particularly in patients with adverse cytogenetics. Strengthening infection control measures, implementing rapid molecular diagnostics, and optimizing antimicrobial stewardship are essential to improve outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteDrug Resistance, Multiple, BacterialHumansMaleFemaleMiddle AgedAgedRetrospective StudiesAdultPrognosisAnti-Bacterial AgentsAged, 80 and overYoung Adult

Stichwörter der Autor:innen

Acute myeloid leukemiaGram-negative bacterial infectionsdrug resistanceprognosis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.
  • Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil.
  • Medical student, Department of Medicine, Itaperi Campus, State University of Ceará (UECE), Fortaleza, CE, Brazil.
  • Department of Medicine, Clinical Genetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.
  • Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.

Zitieren

APA

DE Sousa Oliveira, D., DE Pinho Pessoa, F. M. C., Pontes, I. L., DE Albuquerque Cordeiro, K. M., Dias Nogueira, B. M., DE Morais, G. P., Ribeiro, R. M., Silva, F. A. C., Gurgel, L. A., DE Moraes Filho, M. O., DE Moraes, M. E. A., & Moreira-Nunes, C. A. (2025). Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia. Anticancer Research. https://doi.org/10.21873/anticanres.17690

Vancouver

DE Sousa Oliveira D, DE Pinho Pessoa FMC, Pontes IL, DE Albuquerque Cordeiro KM, Dias Nogueira BM, DE Morais GP, et al. Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia. Anticancer Research. 2025. doi:10.21873/anticanres.17690

BibTeX
@article{DESousaOliveira2025,
  author = {DE Sousa Oliveira, Deivide and DE Pinho Pessoa, Flávia Melo Cunha and Pontes, Isadora Lima and DE Albuquerque Cordeiro, Kaira Mara and Dias Nogueira, Beatriz Maria and DE Morais, Guilherme Passos and Ribeiro, Rodrigo Monteiro and Silva, Fabiana Aguiar Carneiro and Gurgel, Lívia Andrade and DE Moraes Filho, Manoel Odorico and DE Moraes, Maria Elisabete Amaral and Moreira-Nunes, Caroline Aquino},
  title = {Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17690}
}
Kostenlos starten →